Based on these quantification methods, the melanoma marker Mel-A expression in the lung tissues was classified as positive and low positive/negative (42% and 37%) for the tumor control group, and as low positive/negative for the DET- (77%) and DETD-35-treated (59%) groups (Figure 7A), and the proliferation marker Ki67 was classified as positive and low positive/negative for the tumor control group (35% and 39%) and low positive/negative for the DET-treated (77%) and DETD-35-treated (72%) groups (Figure 7B). Here, MKI67 is linked to neoplasm.